agil post strong top bottom beat rais guidanc magnitud
beat given guidanc preced end market hold serv like room
upsid agil continu fire cylind guidanc demonstr
momentum slow revis p-t repres p/fcf ebitda
dcf analysi
revenu ahead expect core growth
y/i expect essenti everi end market geographi
well ahead expect except clinic line
one time tailwind push order pull forward china revenu like
aggreg y/i even fulli exclud fair
order time known prior result agil post underli core growth
gross margin came forecast consensu
adjust oper margin forecast
consensu rel model strong upsid despit wors expect opex
leverag ep consensu expect
manag increas core revenu growth guidanc y/i ep
well prior expect updat ep guidanc close
prior upsid case fx help still impress
said import note seem aggress guidanc increas
actual larg function adjust upsid fx given preced end
market hold serv like room upsid fx expect repres
y/i tailwind revenu growth vs prior model due recent
guidanc send bullish signal core growth expect y/i howev
exclud one time headwind pull forward revenu
headwind china lunar new year impli underli organ growth rate
 impress given y/i comparison year stack comparison
given manag preced guidanc strong signal underli
much pick updat near long term outlook peer
averag revenu growth margin expans ep remain firmli intact momentum
show sign slow valuat remain factor keep us market
perform p-t repres dcf analysi p/fcf ebitda
repres premium vs peer
pleas see page report import disclosur
continu view agil posit competit perspect continu
believ compani potenti gener signific margin expans next
sever year confid manag margin target believ could
room upsid look view guidanc rel conserv
clear potenti driver upsid seemingli littl downsid risk
top bottom line either buyer seller could drive upsid also
provid downsid protect like near long term outlook would await
attract entri point rate share market perform price target base
dcf analysi
agil acquir larger
possibl addit
multipl group
organ growth oper margin
exceed
growth expect
lack growth render multipl high
growth lower expect
expect margin expans fail
life scienc diagnost chemic analysi compani
compani current oper segment life scienc appli market lsag
diagnost genom dgg agil crosslab group acg
compani report thomson eikon cowen compani
cowen vs consensu mm except core fx core gross report segment metric mm except growth growth growth statement mm except growth currenc margin better expect ad beat pre-tax per count consensu lsag revenu came ahead expect core growth y/i ahead expect upsid driven essenti everi end market geographi manag note europ pharma order push close recov manag also note pull forward china revenu due lunar new year time regardless impress quarter guidanc suggest order momentum remain robust streetaccount consensu dgg revenu expect core growth forecast manag note strong demand patholog companion diagnost servic region china america led growth margin quarter expect though manag note line intern expect result driven entir unfavor product mix streetaccount consensu acg revenu came expect core growth expect manag note balanc growth across servic consum china food lead growth sg expens greater expect greater expect sale expect line sale gross margin came expect upsid driven entir lsag acg well expect dgg expect attribut product revenu ahead expect core growth y/i roughli expect one time tailwind quarter even exclud growth ahead expect essenti everi end market ahead expect except clinic biggest surpris academic/gov environmental/forens food tough comp china revenu grew high teen y/i strong quarter oper margin expect consensu strong upsid driven despit less opex leverag expect gross margin well expect ep expect strong top bottom beat cowen
compani report cowen compani
mm except per share datajan net net core fx arevenu acq core fx currenc contribut adjust segmentlif scienc appli group currenc contribut adjust crosslab group currenc contribut adjust genom group currenc contribut adjust currenc currenc pacif expect growth china currenc end marketpharma msd growth growth growth lsd-msd growth lsd-msd growth lsd-msd growth cowen
compani report thomson eikon cowen compani
mm except per share datajan core fx aorgan core fx aconst gener oper report adjust non-oper incl keysight bill net interest net interest expens tax rate re-affirmed net earn per expectationsjan gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk downsid includ limit macroeconom deterior
current level challeng china disrupt due keysight spin eros market
share price due competit inabl deliv incremental/decrement margin
target value-destruct
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen credit research trade due natur fix incom market issuer debt secur issuer discuss cowen credit research trade
research report assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon
analysi reflect analyst opinion date report expect continu analysi addit report relat issuer debt secur
time time cowen credit research trade research analyst provid invest recommend secur subject report
recommend intend time date public within paramet specifi individu report cowen credit research trade
invest recommend made strictli case-by-cas basi recommend provid part overarch rate system set consist
appli benchmark view express report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc februari et dissemin februari et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
